2Grayston J T,Kuo C C,Campbell LA,et al.Proposal to create the Chlamydiasp nov for Chlamydia strain TWAR[J].Int J Syst Bacteriol 1989,39:88-90.
3Grayston J T.Chlamydiae Pneumoniae and atherosclerosis[J].Clin Infect Dis 2005,40:1131-1132.
4Campbell L A,Kuo C C.Chlamydiae Pneumoniae,an infectious risk factor for atherosclerosis[J].Nature Med Microbiol 2004,2:23-32.
5Chirgw in K,Roblin P M,Gelling M,et al.Infection with Chlamydiae Pneumoniae in Brook lyn[J].J Infect Dis 1991,163:757.
6Maass M,Haring U.Evaluation of culture conditions used for isolation of Chlamydiae Pneumoniae[J].Clinic Microbiol Infect Dis 1996,103 (2):141.
7Cles L.We use of HL cells for improved isolation and passage of Chlamydiae Pneumoniae[J].J Cline microbial 2004,28(5):938-940.
8Wang K H,Skelton S K,Chan Y K.Efficient culture of Chlamydiae Pneumoniae with cell llines derived from the human respiratory tract[J].J Cline microbial 2002,30(7):1625-1630.
9Roblin P M,Dumornay W,Hammerschlag M R,et al.Use of Hep-2 cells for improved isolation and passage of Chlamydia pneumoniae[J].J Clinic Microbiol 1992,30(8):1968-1971.
10Maass M,Harig U.Evalution of culture condition used for isolation of Chlamvdia pneumoniae[J].J Clinic Microbiol infect Dis 1996;103(2):141-148.
